LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Octreotide to treat severe hypoglycaemia in Guillain-Barre syndrome

Photo by helloimnik from unsplash

The recovery course of patients with Guillain-Barre syndrome (GBS) can be complicated by non-neurological systemic perturbations. Autonomic dysfunction associated with GBS affects up to two-thirds of patients and can lead… Click to show full abstract

The recovery course of patients with Guillain-Barre syndrome (GBS) can be complicated by non-neurological systemic perturbations. Autonomic dysfunction associated with GBS affects up to two-thirds of patients and can lead to a reduction in the counterregulatory catecholamine response. This increases the risk of severe hypoglycaemia, especially in diabetics.[1] Sudden, severe hypoglycaemia can damage both white and gray matter of the cerebrum resulting in encephalopathy.[2] Attention to glycaemic control is an extremely crucial component in the management of these patients. Due to associated autonomic instability, the warning signs of fatal hypoglycaemia may go unnoticed,[3] like the index case discussed herein. The patient was not a diabetic,

Keywords: severe hypoglycaemia; guillain barre; octreotide treat; treat severe; hypoglycaemia; barre syndrome

Journal Title: Indian Journal of Anaesthesia
Year Published: 2022

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.